Soleus Capital Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85M | Hold |
2,262,026
| – | – | 0.25% | 59 |
|
|
2025
Q1 | $3.57M | Hold |
2,262,026
| – | – | 0.26% | 54 |
|
|
2024
Q4 | $4.05M | Sell |
2,262,026
-2,026,141
| -47% | -$3.63M | 0.25% | 56 |
|
|
2024
Q3 | $26M | Buy |
4,288,167
+77,630
| +2% | +$470K | 2.01% | 14 |
|
|
2024
Q2 | $22.1M | Buy |
4,210,537
+620,979
| +17% | +$3.27M | 1.95% | 16 |
|
|
2024
Q1 | $30.5M | Sell |
3,589,558
-738,064
| -17% | -$6.27M | 2.26% | 9 |
|
|
2023
Q4 | $28.6M | Buy |
4,327,622
+40,528
| +0.9% | +$267K | 3.17% | 10 |
|
|
2023
Q3 | $13.2M | Buy |
4,287,094
+85,000
| +2% | +$263K | 1.22% | 29 |
|
|
2023
Q2 | $11.3M | Buy |
4,202,094
+56,977
| +1% | +$154K | 1.26% | 22 |
|
|
2023
Q1 | $12.3M | Buy |
4,145,117
+275,725
| +7% | +$819K | 1.27% | 22 |
|
|
2022
Q4 | $9.75M | Buy |
3,869,392
+1,228,853
| +47% | +$3.1M | 1.4% | 25 |
|
|
2022
Q3 | $4.81M | Sell |
2,640,539
-1,528,260
| -37% | -$2.78M | 0.65% | 43 |
|
|
2022
Q2 | $13.1M | Sell |
4,168,799
-55,000
| -1% | -$173K | 2.05% | 12 |
|
|
2022
Q1 | $26.1M | Buy |
4,223,799
+698,342
| +20% | +$4.32M | 3.37% | 2 |
|
|
2021
Q4 | $50.1M | Buy |
3,525,457
+657,434
| +23% | +$9.34M | 5.01% | 2 |
|
|
2021
Q3 | $22.9M | Buy |
2,868,023
+629,919
| +28% | +$5.04M | 3.58% | 7 |
|
|
2021
Q2 | $63.9M | Buy |
2,238,104
+168,052
| +8% | +$4.8M | 9.83% | 2 |
|
|
2021
Q1 | $60.1M | Sell |
2,070,052
-305,629
| -13% | -$8.88M | 10.84% | 2 |
|
|
2020
Q4 | $28.3M | Buy |
2,375,681
+548,701
| +30% | +$6.55M | 3.74% | 2 |
|
|
2020
Q3 | $12.6M | Sell |
1,826,980
-255,205
| -12% | -$1.76M | 6.68% | 1 |
|
|
2020
Q2 | $12.9M | Buy |
2,082,185
+1,764
| +0.1% | +$10.9K | 7.36% | 2 |
|
|
2020
Q1 | $8.32M | Buy |
2,080,421
+446,052
| +27% | +$1.78M | 9.68% | 1 |
|
|
2019
Q4 | $8.99M | Buy |
+1,634,369
| New | +$8.99M | 8.67% | 2 |
|